Donor and Recipient Mismatch in Liver Transplantation
DR-MM in LT
1 other identifier
observational
1,146
1 country
1
Brief Summary
This observational study aims to investigate the impact of gender disparity between donors and recipients on long-term outcomes after liver transplantation (LT). The study aims to answer the following question: Does gender mismatch lower the possibility of survival after liver transplantation? Participants demonstrate gender dicrepancies between donors and recipients as regular concept in LT. The retrospective cohort study investigates the impact over a long-term follow up of 10 years.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2014
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
November 18, 2025
CompletedFirst Posted
Study publicly available on registry
November 26, 2025
CompletedFebruary 13, 2026
October 1, 2025
8 years
November 18, 2025
February 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient survival
Overall survival of patients who underwent liver transplantation at the Ajmera transplant centre toronto between 2014 and 2022
Liver transplantation between 01.01.2014 and 01.01.2022, Patient Survival: observatory period between 01.01.2014 and 01.01.2024
Study Arms (2)
GM +
Liver transplant recipients with gender mismatch
GM -
Liver transplant recipients without gender mismatch
Eligibility Criteria
Patients who underwent liver transplantation at who at the Ajmera transplant centre, Toronto between 2014 and 2022
You may qualify if:
- Patients over the age of 18
You may not qualify if:
- Cases of retransplantation
- Combined organ transplantation
- Cases with \>30% of missing values
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Jenalead
- University Health Network, Torontocollaborator
Study Sites (1)
Ajmera Transplant Centre, Toronto General Hospital, University Health Network, Toronto
Toronto, Ontario, Canada
Related Publications (1)
Ghinolfi D, Melandro F, Torri F, Martinelli C, Cappello V, Babboni S, Silvestrini B, De Simone P, Basta G, Del Turco S. Extended criteria grafts and emerging therapeutics strategy in liver transplantation. The unstable balance between damage and repair. Transplant Rev (Orlando). 2021 Dec;35(4):100639. doi: 10.1016/j.trre.2021.100639. Epub 2021 Jul 16.
PMID: 34303259BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 18, 2025
First Posted
November 26, 2025
Study Start
January 1, 2014
Primary Completion
January 1, 2022
Study Completion
January 1, 2024
Last Updated
February 13, 2026
Record last verified: 2025-10